What is Eteplirsen: Uses, Dosage, Side Effects and More

Eteplirsen is a specialized medication designed to help children and adults with a specific type of muscular dystrophy called Duchenne muscular dystrophy (DMD). This medicine works by helping muscle cells produce a modified version of a protein called dystrophin, which is essential for muscle function. While it doesn't cure DMD, eteplirsen can help slow down muscle weakness in people who have certain genetic mutations that cause this condition.

What is Eteplirsen?

Eteplirsen is an antisense oligonucleotide medication that targets the genetic cause of Duchenne muscular dystrophy. It's given through an intravenous (IV) infusion directly into your bloodstream. The medication is specifically designed for people whose DMD is caused by mutations that can benefit from "exon 51 skipping" - a process that helps cells make a shorter but functional version of the dystrophin protein.

This medication belongs to a newer class of treatments called gene-targeted therapies. Unlike traditional medicines that just treat symptoms, eteplirsen works at the genetic level to help your body produce proteins it normally can't make properly. The drug was approved by the FDA in 2016 specifically for DMD patients who have genetic mutations that respond to this type of treatment.

What is Eteplirsen Used For?

Eteplirsen is used to treat Duchenne muscular dystrophy in patients who have genetic mutations that can benefit from exon 51 skipping. DMD is a progressive muscle-wasting disease that primarily affects boys and young men, causing gradual weakness and loss of muscle function over time.

The medication is specifically approved for people whose genetic testing shows they have mutations that make up about 13% of all DMD cases. Your doctor will need to confirm through genetic testing that your specific type of DMD mutation can benefit from this treatment. Not everyone with DMD will be a candidate for eteplirsen - it only works for certain genetic subtypes of the condition.

This treatment aims to slow down the progression of muscle weakness and help maintain muscle function for as long as possible. While it's not a cure, it can help people with DMD maintain their ability to walk and perform daily activities for longer periods than they might without treatment.

How Does Eteplirsen Work?

Eteplirsen works by helping your muscle cells "skip over" a problematic section of genetic code that prevents them from making dystrophin protein. Think of it like editing a sentence by removing a word that doesn't belong - the remaining sentence still makes sense and can be understood.

In people with DMD, genetic mutations disrupt the instructions for making dystrophin, a protein that helps keep muscle fibers strong and intact. Eteplirsen binds to the genetic material in muscle cells and helps them ignore the faulty section, allowing them to produce a shorter but functional version of dystrophin. This modified protein isn't as robust as normal dystrophin, but it can still help protect muscle fibers from damage.

The medication is considered a moderate-strength treatment option. It's not as immediately powerful as some other medications, but it addresses the root genetic cause of the condition rather than just managing symptoms. The effects build up gradually over time as your muscle cells begin producing more of the modified dystrophin protein.

How Should I Take Eteplirsen?

Eteplirsen is given as an intravenous infusion in a healthcare setting, typically a hospital or specialized clinic. You'll receive the medication through a small tube placed in a vein, usually in your arm. The infusion takes about 35 to 60 minutes to complete, and you'll need to receive it once a week.

Before each infusion, you don't need to make any special dietary changes or take the medication with food since it goes directly into your bloodstream. However, it's important to stay well-hydrated by drinking plenty of water before and after your treatment. Your healthcare team will monitor you during the infusion to make sure you're tolerating the medication well.

You'll need to plan your schedule around these weekly appointments, as consistency is important for the medication to work effectively. Your healthcare team will work with you to find a regular time that fits your routine. Some people find it helpful to schedule their infusions on the same day each week to establish a routine.

How Long Should I Take Eteplirsen For?

Eteplirsen is typically a long-term treatment that you'll likely continue for years, possibly indefinitely. Because DMD is a progressive condition, stopping the medication could allow muscle weakness to progress more rapidly again.

Your doctor will monitor your response to the medication through regular check-ups, including tests to measure muscle function and strength. They'll assess whether the treatment is helping slow down muscle deterioration and maintaining your quality of life. Some people may see benefits within the first few months, while others might need to continue treatment for six months or longer before noticing improvements.

The decision about how long to continue treatment depends on several factors, including how well you're responding to the medication, whether you're experiencing any concerning side effects, and your overall health status. Your medical team will regularly review your progress and discuss whether continuing treatment remains the best option for you.

What Are the Side Effects of Eteplirsen?

Like all medications, eteplirsen can cause side effects, though not everyone experiences them. Most side effects are mild to moderate and manageable with proper medical care.

The most common side effects you might experience include balance problems, vomiting, and reactions at the infusion site where the IV is placed. Some people also report feeling tired or experiencing minor skin irritation. These effects often improve as your body adjusts to the medication over the first few weeks of treatment.

Here are the side effects that occur most frequently, keeping in mind that many people tolerate the medication well:

• Balance problems or feeling unsteady
• Nausea or vomiting
• Redness, swelling, or pain at the IV site
• Fatigue or feeling more tired than usual
• Headache
• Fever or feeling feverish
• Cough or throat irritation

Most of these side effects are temporary and manageable. Your healthcare team can provide strategies to help minimize discomfort, such as taking the infusion more slowly or using medications to prevent nausea.

While rare, some people may experience more serious side effects that require immediate medical attention. These serious reactions are uncommon but important to recognize:

• Severe allergic reactions with difficulty breathing or swelling of the face, lips, or throat
• Significant kidney problems, which might show up as changes in urination or swelling in your legs
• Severe infusion reactions with chest pain, rapid heartbeat, or severe dizziness
• Signs of infection such as persistent fever, chills, or unusual weakness

If you experience any of these serious symptoms, contact your healthcare provider immediately or seek emergency medical care. Your medical team will monitor you closely, especially during your first few infusions, to watch for any concerning reactions.

Who Should Not Take Eteplirsen?

Eteplirsen isn't appropriate for everyone, even among people with Duchenne muscular dystrophy. The most important factor is whether your specific genetic mutation can benefit from exon 51 skipping - genetic testing will determine this.

People who have had severe allergic reactions to eteplirsen or any of its components should not receive this medication. Additionally, if you have significant kidney problems, your doctor may need to adjust your treatment plan or consider alternative options, as the medication can affect kidney function.

Here are the main situations where eteplirsen might not be recommended, though each case requires individual medical evaluation:

• DMD caused by genetic mutations that don't respond to exon 51 skipping
• Previous severe allergic reactions to eteplirsen
• Severe kidney disease or kidney failure
• Active, uncontrolled infections
• Certain heart conditions that might make IV infusions risky

Your doctor will carefully review your medical history and current health status before recommending eteplirsen. They may also want to coordinate with other specialists, such as cardiologists or kidney specialists, to ensure the treatment is safe for your specific situation.

Eteplirsen Brand Name

Eteplirsen is sold under the brand name Exondys 51 in the United States. This is the only brand name currently available for this medication, as it's manufactured by a single pharmaceutical company.

When you receive your treatment or discuss it with healthcare providers, you might hear it referred to by either name - eteplirsen or Exondys 51. Both names refer to the same medication. The brand name Exondys 51 reflects the medication's mechanism of action, as it works by skipping exon 51 in the genetic code.

Eteplirsen Alternatives

Several other medications are available for treating Duchenne muscular dystrophy, though each works differently and targets different aspects of the condition. The best alternative depends on your specific genetic mutation and individual health circumstances.

Corticosteroids like prednisone and deflazacort are commonly used treatments that can help slow muscle weakness progression. These medications work by reducing inflammation in muscles rather than targeting the genetic cause like eteplirsen does. While effective, they can have more significant side effects with long-term use, including weight gain and bone weakness.

Other antisense oligonucleotide medications are available for different genetic subtypes of DMD. Golodirsen targets exon 53 skipping, while casimersen works on exon 45 skipping. These work similarly to eteplirsen but are designed for people with different genetic mutations. Gene therapy approaches are also being developed, though many are still in clinical trials.

Is Eteplirsen Better Than Deflazacort?

Eteplirsen and deflazacort work in completely different ways, so comparing them directly isn't straightforward. Both medications can be valuable in treating DMD, and some people may benefit from using both together under careful medical supervision.

Eteplirsen targets the genetic root cause of DMD by helping cells produce dystrophin protein, while deflazacort is a corticosteroid that reduces muscle inflammation and may help preserve muscle function. Deflazacort has been used longer and has more extensive research data showing its effects on muscle strength and function.

The choice between these medications depends on several factors, including your specific genetic mutation, current symptoms, age, and tolerance for different types of side effects. Eteplirsen is only effective for people with specific genetic mutations, while deflazacort can potentially help anyone with DMD regardless of their genetic subtype. Your doctor will consider your individual situation to determine which treatment approach is most appropriate for you.